CY1111101T1 - Παραγωγα του 5-πυριδαζινυλ-1-αζαδικυκλο[3.2.1] οκτανιου, μια μεθοδος παρασκευης τους και η χρηση τους στη θεραπευτικη - Google Patents
Παραγωγα του 5-πυριδαζινυλ-1-αζαδικυκλο[3.2.1] οκτανιου, μια μεθοδος παρασκευης τους και η χρηση τους στη θεραπευτικηInfo
- Publication number
- CY1111101T1 CY1111101T1 CY20111100037T CY111100037T CY1111101T1 CY 1111101 T1 CY1111101 T1 CY 1111101T1 CY 20111100037 T CY20111100037 T CY 20111100037T CY 111100037 T CY111100037 T CY 111100037T CY 1111101 T1 CY1111101 T1 CY 1111101T1
- Authority
- CY
- Cyprus
- Prior art keywords
- group
- alkyl
- trifluoromethoxy
- alkylamino
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Abstract
Η παρούσα εφεύρεση αφορά σε ενώσεις με το γενικό τύπο (I) στον οποίο το R αντιπροσωπεύει είτε ένα άτομο υδρογόνου είτε ένα άτομο αλογόνου, είτε μία ομάδα φαινυλίου ενδεχομένως υποκατεστημένη με ένα ή περισσότερα άτομα αλογόνου, με μία ή περισσότερες ομάδες οι οποίες επιλέγονται από τις ομάδες (C1-C6)αλκυλίου, (C1-C6)αλκοξυλίου, νιτροομάδας, αμινοομάδας, δι(C1-C3)αλκυλαμινοομάδας, τριφθορομεθυλίου, τριφθορομεθοξυλίου, κυανοομάδας, υδροξυλίου, ακετυλίου ή μεθυλενοδιοξυλίου, είτε μία ομάδα η οποία επιλέγεται από τα πιριδινύλιο, πυραζολύλιο, ιμιδαζολύλιο, τριαζολύλιο, τετραζολύλιο, οξαζολύλιο, θειαζολύλιο, οξαδιαζολύλιο, θειαδιαζολύλιο, θεινύλιο, φουρύλιο, ισοξαζολύλιο, ισοθειαζολύλιο, πυρρολύλιο, ναφθύλιο, η ομάδα αυτή είναι ενδεχομένως δυνατό να είναι υποκατεστημένη με μία ή περισσότερες ομάδες οι οποίες επιλέγονται από τα άτομα των αλογόνων, τις ομάδες (C1-C6)αλκυλίου, (C1-C6)αλκοξυλίου, τριφθορομεθοξυλίου, τριφθορομεθυλίου, νιτροομάδας, κυανοομάδας, υδροξυλίου, αμινοομάδας, (C1-C6) αλκυλαμινοομάδας ή δι(C1-C6), αλκυλαμινοομάδας σε κατάσταση βάσης ή όξινου άλατος προσθήκης, καθώς και σε κατάσταση ένυδρου άλατος ή επιδιαλυτωμένου χημικού σωματιδίου. Μέθοδος παρασκευής και εφαρμογή στη θεραπευτική.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0508594A FR2889847B1 (fr) | 2005-08-18 | 2005-08-18 | Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique. |
| EP06794297A EP1922320B1 (fr) | 2005-08-18 | 2006-08-07 | Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111101T1 true CY1111101T1 (el) | 2015-06-11 |
Family
ID=36297201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100037T CY1111101T1 (el) | 2005-08-18 | 2011-01-12 | Παραγωγα του 5-πυριδαζινυλ-1-αζαδικυκλο[3.2.1] οκτανιου, μια μεθοδος παρασκευης τους και η χρηση τους στη θεραπευτικη |
Country Status (40)
| Country | Link |
|---|---|
| US (3) | US7476674B2 (el) |
| EP (1) | EP1922320B1 (el) |
| JP (1) | JP5249758B2 (el) |
| KR (1) | KR101260546B1 (el) |
| CN (2) | CN101291933B (el) |
| AR (1) | AR056461A1 (el) |
| AT (1) | ATE486073T1 (el) |
| AU (1) | AU2006281340B2 (el) |
| BR (1) | BRPI0614796A2 (el) |
| CA (1) | CA2618110C (el) |
| CR (1) | CR9693A (el) |
| CY (1) | CY1111101T1 (el) |
| DE (1) | DE602006017854D1 (el) |
| DK (1) | DK1922320T3 (el) |
| DO (1) | DOP2006000191A (el) |
| EA (1) | EA013601B1 (el) |
| EC (1) | ECSP088182A (el) |
| ES (1) | ES2354833T3 (el) |
| FR (1) | FR2889847B1 (el) |
| HK (1) | HK1125628A1 (el) |
| HN (1) | HN2008000276A (el) |
| HR (1) | HRP20110043T1 (el) |
| IL (1) | IL189014A0 (el) |
| JO (1) | JO2680B1 (el) |
| MA (1) | MA29913B1 (el) |
| MX (1) | MX2008002276A (el) |
| MY (1) | MY145923A (el) |
| NO (1) | NO20081289L (el) |
| NZ (1) | NZ565537A (el) |
| PE (1) | PE20070234A1 (el) |
| PL (1) | PL1922320T3 (el) |
| PT (1) | PT1922320E (el) |
| RS (1) | RS51653B (el) |
| SI (1) | SI1922320T1 (el) |
| TN (1) | TNSN08026A1 (el) |
| TW (1) | TWI322808B (el) |
| UA (1) | UA92360C2 (el) |
| UY (1) | UY29756A1 (el) |
| WO (1) | WO2007020343A1 (el) |
| ZA (1) | ZA200800966B (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9249307B2 (en) | 2011-08-16 | 2016-02-02 | Pierce Biotechnology, Inc. | Benzocyanine compounds |
| JP7476100B2 (ja) | 2018-07-19 | 2024-04-30 | 住友ファーマ株式会社 | ピリダジノン誘導体 |
| EP4104861A4 (en) | 2020-01-07 | 2024-01-17 | Sumitomo Pharma Co Ltd | THERAPEUTIC FOR TAUOPATHIES |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786769B1 (fr) * | 1998-12-04 | 2002-10-25 | Synthelabo | Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique |
| FR2786770B1 (fr) * | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
| US6277855B1 (en) | 2000-04-21 | 2001-08-21 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| ES2223209B1 (es) | 2001-12-11 | 2005-10-01 | Esteve Quimica, S.A. | Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion. |
| ATE334979T1 (de) | 2000-10-13 | 2006-08-15 | Neurosearch As | Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz |
| FR2834511B1 (fr) * | 2002-01-07 | 2004-02-13 | Sanofi Synthelabo | Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique |
| US6644511B2 (en) | 2002-01-11 | 2003-11-11 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Container for dispensing a dual phase fluid product |
-
2005
- 2005-08-18 FR FR0508594A patent/FR2889847B1/fr not_active Expired - Fee Related
-
2006
- 2006-07-26 JO JO2006251A patent/JO2680B1/en active
- 2006-08-07 ES ES06794297T patent/ES2354833T3/es active Active
- 2006-08-07 CA CA2618110A patent/CA2618110C/fr not_active Expired - Fee Related
- 2006-08-07 RS RS20110011A patent/RS51653B/en unknown
- 2006-08-07 MX MX2008002276A patent/MX2008002276A/es active IP Right Grant
- 2006-08-07 DK DK06794297.9T patent/DK1922320T3/da active
- 2006-08-07 NZ NZ565537A patent/NZ565537A/en not_active IP Right Cessation
- 2006-08-07 SI SI200630880T patent/SI1922320T1/sl unknown
- 2006-08-07 CN CN2006800297295A patent/CN101291933B/zh not_active Expired - Fee Related
- 2006-08-07 EP EP06794297A patent/EP1922320B1/fr active Active
- 2006-08-07 CN CN2011104283877A patent/CN102558177A/zh active Pending
- 2006-08-07 AT AT06794297T patent/ATE486073T1/de active
- 2006-08-07 WO PCT/FR2006/001911 patent/WO2007020343A1/fr active Application Filing
- 2006-08-07 UA UAA200803421A patent/UA92360C2/ru unknown
- 2006-08-07 AU AU2006281340A patent/AU2006281340B2/en not_active Ceased
- 2006-08-07 PT PT06794297T patent/PT1922320E/pt unknown
- 2006-08-07 EA EA200800615A patent/EA013601B1/ru not_active IP Right Cessation
- 2006-08-07 DE DE602006017854T patent/DE602006017854D1/de active Active
- 2006-08-07 JP JP2008526522A patent/JP5249758B2/ja not_active Expired - Fee Related
- 2006-08-07 BR BRPI0614796-8A patent/BRPI0614796A2/pt not_active IP Right Cessation
- 2006-08-07 PL PL06794297T patent/PL1922320T3/pl unknown
- 2006-08-15 PE PE2006000988A patent/PE20070234A1/es not_active Application Discontinuation
- 2006-08-16 MY MYPI20063961A patent/MY145923A/en unknown
- 2006-08-16 AR ARP060103567A patent/AR056461A1/es unknown
- 2006-08-17 TW TW095130289A patent/TWI322808B/zh not_active IP Right Cessation
- 2006-08-18 UY UY29756A patent/UY29756A1/es unknown
- 2006-08-18 DO DO2006000191A patent/DOP2006000191A/es unknown
-
2008
- 2008-01-18 TN TNP2008000026A patent/TNSN08026A1/en unknown
- 2008-01-24 IL IL189014A patent/IL189014A0/en not_active IP Right Cessation
- 2008-01-25 CR CR9693A patent/CR9693A/es unknown
- 2008-02-11 US US12/029,008 patent/US7476674B2/en not_active Expired - Fee Related
- 2008-02-13 EC EC2008008182A patent/ECSP088182A/es unknown
- 2008-02-15 KR KR1020087003657A patent/KR101260546B1/ko not_active IP Right Cessation
- 2008-02-18 HN HN2008000276A patent/HN2008000276A/es unknown
- 2008-03-07 MA MA30721A patent/MA29913B1/fr unknown
- 2008-03-11 NO NO20081289A patent/NO20081289L/no not_active Application Discontinuation
- 2008-08-07 ZA ZA200800966A patent/ZA200800966B/xx unknown
- 2008-12-05 US US12/328,804 patent/US8076340B2/en not_active Expired - Fee Related
-
2009
- 2009-04-16 HK HK09103512.4A patent/HK1125628A1/xx not_active IP Right Cessation
-
2011
- 2011-01-12 CY CY20111100037T patent/CY1111101T1/el unknown
- 2011-01-20 HR HR20110043T patent/HRP20110043T1/hr unknown
- 2011-11-01 US US13/286,662 patent/US8557819B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124728T1 (el) | Παραγωγα βενζοξαβορολης για τη θεραπεια βακτηριακων λοιμωξεων | |
| CY1123817T1 (el) | Μεθοδος για την παρασκευη ενωσεων που ειναι χρησιμες ως αναστολεις sglt | |
| CY1120081T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
| CY1113764T1 (el) | Βενζοϊκου οξεος (1-φαινυλ-2-πυριδιν-4-υλ) αιθυλ εστερες ως αναστολεις φωσφοδιεστερασης | |
| CY1108792T1 (el) | Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη | |
| CY1116945T1 (el) | Παραγωγα ινδολιζινης, διεργασια για την παρασκευη αυτης και θεραπευτικη χρηση αυτης | |
| CY1111294T1 (el) | Συνθεση αμιδιων ακυλαμινοαλκενυλενιου χρησιμων ως ανταγωνιστων της ουσιας ρ | |
| BRPI0608732A2 (pt) | composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto | |
| CY1115533T1 (el) | Παραγωγα χολικου οξεος ως προσδετες fxr για την προληψη ή τη θεραπευτικη αγωγη νοσηματων ή καταστασεων οι οποιες προκαλουνται με τη μεσολαβηση fxr | |
| BRPI0810929B8 (pt) | uso de um composto de fórmula 1 | |
| EA201101089A1 (ru) | Производные оксадиазола в качестве агонистов рецептора s1p1 | |
| ES2183548T3 (es) | Dihidropirimidinas. | |
| CY1109227T1 (el) | Παραγωγα της 5-φαινυλο-4-μεθυλο-θειαζολ-2-υλ-αμινης ως αναστολεις των ενζυμων κινασης της φωσφατιδυλινοσιτολης 3 (p13) για την θεραπεια των φλεγμονωδων ασθενειων των αεραγωγων | |
| EA201791254A1 (ru) | Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета | |
| CY1110956T1 (el) | Παραγωγα πυριδο-πυραζινης χρησιμα ως ζιζανιοκτονες ενωσεις | |
| GT200400092A (es) | Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad | |
| MX2009011213A (es) | Derivados de triazolopiridina carboxamida y triazolopirimidina carboxamida, su preparacion y su aplicacion terapeutica. | |
| CY1108752T1 (el) | Παραγωγα πουρινης δρωντα ως αγωνιστες του α2α-υποδοχεα | |
| NO20074763L (no) | (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi | |
| WO2009047298A3 (en) | Dimers of harmol or of its derivatives and uses thereof | |
| CY1109964T1 (el) | Ετεροκυκλικοι δακτυλιοι συντηγμενοι με 1,4-διυδροπυριδινη, η διαδικασια παρασκευης τους, η χρηση και οι συνθεσεις που τους περιεχουν | |
| CY1111601T1 (el) | Παραγωγα καρβοξαμιδιων της τριαζολοπυριδινης, η παρασκευη τους και η θεραπευτικη χρηση τους | |
| CY1108366T1 (el) | Βενζοσουλφονικο αλας της 7-(2-(4-(3-τριφθορομεθυλ-φαινυλ-1,2,3,6-τετραϋδρο-πυριδ-1-υλ)αιθυλ)ισοκινολινης, η παρασκευη του και η χρηση του στη φαρμακευτικη αγωγη | |
| CY1115256T1 (el) | Φαρμακευτικες ενωσεις | |
| CY1116875T1 (el) | Διϋδροετορφινες και η παρασκευη αυτων |